Cargando…

End-to-end test for computed tomography-based high-dose-rate brachytherapy

PURPOSE: One of the important developments in brachytherapy in recent years has been the clinical implementation of complex modern technical procedures. Today, 3D-imaging has become the standard procedure and it is used for contouring and precise position determination and reconstruction of used bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Krause, Fabian, Risske, Franziska, Bohn, Susann, Delaperriere, Marc, Dunst, Jürgen, Siebert, Frank-André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335556/
https://www.ncbi.nlm.nih.gov/pubmed/30662478
http://dx.doi.org/10.5114/jcb.2018.81026
_version_ 1783387908120510464
author Krause, Fabian
Risske, Franziska
Bohn, Susann
Delaperriere, Marc
Dunst, Jürgen
Siebert, Frank-André
author_facet Krause, Fabian
Risske, Franziska
Bohn, Susann
Delaperriere, Marc
Dunst, Jürgen
Siebert, Frank-André
author_sort Krause, Fabian
collection PubMed
description PURPOSE: One of the important developments in brachytherapy in recent years has been the clinical implementation of complex modern technical procedures. Today, 3D-imaging has become the standard procedure and it is used for contouring and precise position determination and reconstruction of used brachytherapy applicators. Treatment planning is performed on the basis of these imaging methods, followed by data transfer to the afterloading device. Therefore, checking the entire treatment chain is of high importance. In this work, we describe an end-to-end test for computed tomography (CT)-based brachytherapy with an high-dose-rate (HDR) afterloading device, which fulfills the recommendation of the German radiation-protection-commission. MATERIAL AND METHODS: The treatment chain consists of a SOMATOM S64 CT scanner (Siemens Medical), the treatment planning system (TPS) BrachyVision v.13.7 (VMS), which utilizes the calculation formalism TG-43 and the Acuros algorithm v. 1.5.0 (VMS) as well as GammaMedplus HDR afterloader (VMS) using an Ir-192 source. Measurement setups for common brachytherapy applicators are defined in a water phantom, and the required PMMA applicator holders are developed. These setups are scanned with the CT and the data is imported into the TPS. Computed TPS reference dose values for significant points located on the side of the applicator are compared with dose measurements performed with a PinPoint 3D chamber 31016 (PTW Freiburg). RESULTS: The deviations for the end-to-end test between computed and measured values are shown to be ≤ 5%, when using an implant needle or vaginal cylinder. Furthermore, it can be demonstrated that the test procedure provides reproducible results, while repositioning the applicators without carrying out a new CT-scan. CONCLUSIONS: The end-to-end test presented allows a practice-oriented realization for checking the whole treatment chain for HDR afterloading technique and CT-imaging. The presented phantom seems feasible for performing periodic system checks as well as to verify newly introduced brachytherapy techniques with sufficient accuracy.
format Online
Article
Text
id pubmed-6335556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-63355562019-01-18 End-to-end test for computed tomography-based high-dose-rate brachytherapy Krause, Fabian Risske, Franziska Bohn, Susann Delaperriere, Marc Dunst, Jürgen Siebert, Frank-André J Contemp Brachytherapy Original Paper PURPOSE: One of the important developments in brachytherapy in recent years has been the clinical implementation of complex modern technical procedures. Today, 3D-imaging has become the standard procedure and it is used for contouring and precise position determination and reconstruction of used brachytherapy applicators. Treatment planning is performed on the basis of these imaging methods, followed by data transfer to the afterloading device. Therefore, checking the entire treatment chain is of high importance. In this work, we describe an end-to-end test for computed tomography (CT)-based brachytherapy with an high-dose-rate (HDR) afterloading device, which fulfills the recommendation of the German radiation-protection-commission. MATERIAL AND METHODS: The treatment chain consists of a SOMATOM S64 CT scanner (Siemens Medical), the treatment planning system (TPS) BrachyVision v.13.7 (VMS), which utilizes the calculation formalism TG-43 and the Acuros algorithm v. 1.5.0 (VMS) as well as GammaMedplus HDR afterloader (VMS) using an Ir-192 source. Measurement setups for common brachytherapy applicators are defined in a water phantom, and the required PMMA applicator holders are developed. These setups are scanned with the CT and the data is imported into the TPS. Computed TPS reference dose values for significant points located on the side of the applicator are compared with dose measurements performed with a PinPoint 3D chamber 31016 (PTW Freiburg). RESULTS: The deviations for the end-to-end test between computed and measured values are shown to be ≤ 5%, when using an implant needle or vaginal cylinder. Furthermore, it can be demonstrated that the test procedure provides reproducible results, while repositioning the applicators without carrying out a new CT-scan. CONCLUSIONS: The end-to-end test presented allows a practice-oriented realization for checking the whole treatment chain for HDR afterloading technique and CT-imaging. The presented phantom seems feasible for performing periodic system checks as well as to verify newly introduced brachytherapy techniques with sufficient accuracy. Termedia Publishing House 2018-12-28 2018-12 /pmc/articles/PMC6335556/ /pubmed/30662478 http://dx.doi.org/10.5114/jcb.2018.81026 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Krause, Fabian
Risske, Franziska
Bohn, Susann
Delaperriere, Marc
Dunst, Jürgen
Siebert, Frank-André
End-to-end test for computed tomography-based high-dose-rate brachytherapy
title End-to-end test for computed tomography-based high-dose-rate brachytherapy
title_full End-to-end test for computed tomography-based high-dose-rate brachytherapy
title_fullStr End-to-end test for computed tomography-based high-dose-rate brachytherapy
title_full_unstemmed End-to-end test for computed tomography-based high-dose-rate brachytherapy
title_short End-to-end test for computed tomography-based high-dose-rate brachytherapy
title_sort end-to-end test for computed tomography-based high-dose-rate brachytherapy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335556/
https://www.ncbi.nlm.nih.gov/pubmed/30662478
http://dx.doi.org/10.5114/jcb.2018.81026
work_keys_str_mv AT krausefabian endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy
AT risskefranziska endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy
AT bohnsusann endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy
AT delaperrieremarc endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy
AT dunstjurgen endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy
AT siebertfrankandre endtoendtestforcomputedtomographybasedhighdoseratebrachytherapy